• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    8.58 Down 0.07(0.81%) Apr 24, 4:00PM EDT
    |After Hours : 8.65 Up 0.07 (0.82%) Apr 24, 4:31PM EDT
    Add to Portfolio
    Prev Close:8.65
    Open:8.65
    Bid:8.59 x 300
    Ask:8.68 x 500
    1y Target Est:11.04
    Beta:1.33
    Next Earnings Date: 7-May-15NVAX Earnings announcement
    Day's Range:8.58 - 8.81
    52wk Range:3.70 - 9.95
    Volume:2,409,350
    Avg Vol (3m):4,628,400
    Market Cap:2.05B
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 0.81%2.05B
    MRKUp 0.16%162.92B
    NVSDown 1.16%250.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):67.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.47
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback